Kallmann syndrome
| Kallmann syndrome | |
|---|---|
| Other names | Kallmann's hereditary anosmia |
| Specialty | Endocrinology |
| Symptoms | Absent or delayed puberty, infertility, inability to smell |
| Complications | Osteoporosis |
| Usual onset | Present at birth |
| Duration | Lifelong |
| Treatment | Hormone replacement therapy Gonadotropin therapy |
| Frequency | 1:30,000 (males), 1:125,000 (females) |
Kallmann syndrome (KS) is a genetic disorder that prevents a person from starting or fully completing puberty. Kallmann syndrome is one of a group of conditions termed hypogonadotropic hypogonadism. To distinguish it from other forms of hypogonadotropic hypogonadism, Kallmann syndrome has the additional symptom of a total lack of sense of smell (anosmia) or a reduced sense of smell. If left untreated, people will have poorly defined secondary sexual characteristics, show signs of hypogonadism, almost invariably be infertile and at increased risk of developing osteoporosis. A range of other physical symptoms affecting the face, hands and skeletal system can also occur.